Servier Canada Inc. - Address & business activities

Address:

#270 - 3224 avenue Jean-Béraud
Laval, QC  H7T 2S4
Canada

Telephone number: 514-296-6064

• Contact information in previous versions

  • #270 - 3224 avenue Jean-Béraud
    Laval, QC  H7T 2S4
    Canada
    
    Telephone number: 450-987-9700  Ext. 4225
    
    
  • 235 Armand-Frappier
    Laval, QC  H7V 4A7
    Canada
    
    Telephone number: 450-987-9700  Ext. 4225
    
    
  • 235 Armand-Frappier
    Laval, QC  H7V 4A7
    Canada
    
    Telephone number: 450-978-0409
    
    
  • 235 Armand-Frappier
    Laval, QC  H7V 4A7
    Canada
    
    Telephone number: 780-982-2469
    
    Fax number: 450-978-4082  
    
    
  • 235 Armand-Frappier
    
    Laval, BC  H7V 4A7
    Canada
    
    Telephone number: 780-982-2469
    
    Fax number: 450-978-4082  
    
    
  • 235 Armand-Frappier
    
    Laval, BC  H7V 4A7
    Canada
    
    Telephone number: 450-978-0409
    
    Fax number: 450-978-4082  
    
    
  • 235 Armand-Frappier
    
    Laval, QC  H7V 4A7
    Canada
    
    Telephone number: 450-978-0409
    
    Fax number: 450-978-4082  
    
    
  • 235 Armand-Frappier
    
    Laval, QC  H7V 4A7
    Canada
    
    Telephone number: 450-978-0409
    
    

Description of Activities:
Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 149 countries employing more than 21,700 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes and oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca

• Descriptions of the organization's activity in previous versions:

  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 149 countries employing more than 21,700 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes and oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, an international pharmaceutical company governed by a non-profit foundation, with its global headquarters in France (Suresnes), specializing in ethical pharmaceuticals. With a strong international presence in 148 countries employing more than 21,500 people worldwide, Servier Research Group is entirely independent and reinvests 25% of its turnover from innovative therapies back in to research and development. The mission of Servier Canada is to provide the Canadian medical community and their patients with innovative therapeutic solutions in different therapeutic areas of high unmet needs, like cardiology, diabetes or oncology. Servier Canada collaborates with various stakeholders including researchers, biotech entrepreneurs and innovators. In addition to these partnerships, the Center of Excellence in Clinical Research of Servier Canada is dedicated to clinical development. Servier will not only have innovative new products in its existing therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. Recently, Servier Canada has received approval for 3 new agents. In the future, Servier Canada will add to the portfolio by making new products available for: the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organization, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression, mild cognitive impairment and oncology. For more information please consult : www.servier.ca
  • Servier Canada Inc. is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals. Servier Canada is committed to the investment in research and development. Looking forward to the future, Servier Canada and the whole Servier Research Group is set for significant growth over the next 10 years. From a product portfolio focused on Cardiovascular and Diabetes, Servier will not only have some innovative new products in both of these therapeutic fields, but will enter at least 3 new therapeutic fields in the coming years. In the near future, Servier Canada will make available for patients a portfolio consisting of new and existing products for: hypertension, the prevention of cardiovascular events, type 2 diabetes, depression and mild cognitive impairment. For more information please consult : www.servier.ca

Servier Canada Inc. / Lucie Rousseau, General Manager

NOT USED:

3224 Jean-Béraud Avenue, Office 270
Laval, QC  H7T 2S4
Canada

Telephone number: 514-296-6064

Address:

BioFarma S.A

50 Rue Carnot,Suresnes, Cedex, France 92284
Suresnes  92284

Lobbyists who have performed lobbying activities are required to report whether they have made any political, sponsorship or recall contributions since the date the writ was issued for the last provincial election, even if Elections BC is not yet showing the contribution.